IOVS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Rezai, K. A.
Right arrow Articles by van Seventer, G. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rezai, K. A.
Right arrow Articles by van Seventer, G. A.

Investigative Ophthalmology & Visual Science, Vol 38, 2662-2671, Copyright © 1997 by Association for Research in Vision and Ophthalmology


ARTICLES AND REPORTS

The immunogenic potential of human fetal retinal pigment epithelium and its relation to transplantation

KA Rezai, RT Semnani, SC Patel, JT Ernest and GA van Seventer
Department of Ophthalmology and Visual Science, University of Chicago, IL 60637, USA.

PURPOSE: To perform a quantitative analysis of the expression of major histocompatibility molecules (MHC classes I and II) and costimulatory molecules by human fetal retinal pigment epithelial (HFRPE) cells and to evaluate their potential role in providing costimulatory signals for the activation of human T cells in vitro. METHODS: Pure HFRPE cells were isolated and cultured. The ability of HFRPE cells to express MHC class I and II and costimulatory molecules before and after incubation with interferon (IFN)-gamma was quantitatively analyzed by flow cytometry. The potential of HFRPE cells to activate human T cells was assessed in three different lymphocyte activation models. In the first model, anti-CD3 (OKT3)-coated beads were used to provide the T-cell receptor (TcR) signal. In the second model, the allogenic potential of HFRPE cells was assessed, and in the third assay a potent superantigen (SEA) was used to provide the TcR signal. T-cell activation was determined by cell proliferation, measured by [3H]-thymidine incorporation. RESULTS: The cultured HFRPE cells expressed low levels of MHC class I and ICAM-1 molecules. After incubation with IFN-gamma, the expression of MHC class I and ICAM-1 molecules was further upregulated, and the expression of MHC class II and VCAM-1 molecules was induced. The expression of the costimulatory molecules B7-1 and B7- 2 was not observed in normal or activated HFRPE cells. In the first T- cell activation model, neither normal nor IFN-gamma-activated HFRPE cells could provide T-cell costimulation for anti-CD3 (OKT3)-coated beads. However, the autologous peripheral blood mononuclear cells (PBMCs; used here as the source of antigen-presenting cells) could provide costimulation for the T cells, inducing their proliferation. In the second T-cell activation assay, normal or IFN-gamma-activated HFRPE cells could not stimulate an alloresponse from the T cells, but they could induce a significant alloimmune T-cell response in the presence of PBMCs. In the third T-cell activation assay, the IFN-gamma-activated HFRPE cells were able to provide T-cell costimulation for the SEA- mediated activation. CONCLUSIONS: In these in vitro experiments, the IFN-gamma-activated HFRPE cells stimulated only the T cells with the potent superantigen SEA. In the absence of antigen-presenting cells, the HFRPE cells did not provide T-cell costimulation in an anti-CD3 mAb- coated bead system or induce significant alloimmune response. These results suggest that in transplantation between donors and recipients with different MHC molecules, the direct MHC peptide presentation by HFRPE cells may not induce a significant allospecific immune response. Nevertheless, an allospecific immune response could occur as a consequence of the indirect presentation, to the host T cells by the host antigen-presenting cells, of the HFRPE cells' derived MHC alloantigens.


This article has been cited by other articles:


Home page
Proc. Natl. Acad. Sci. USAHome page
B.-L. L. Seagle, E. M. Gasyna, W. F. Mieler, and J. R. Norris Jr.
Photoprotection of human retinal pigment epithelium cells against blue light-induced apoptosis by melanin free radicals from Sepia officinalis
PNAS, November 7, 2006; 103(45): 16644 - 16648.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
E. Sugano, H. Tomita, S.-i. Ishiguro, T. Abe, and M. Tamai
Establishment of Effective Methods for Transducing Genes into Iris Pigment Epithelial Cells by Using Adeno-associated Virus Type 2
Invest. Ophthalmol. Vis. Sci., September 1, 2005; 46(9): 3341 - 3348.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
S. Wang, B. Lu, P. Wood, and R. D. Lund
Grafting of ARPE-19 and Schwann Cells to the Subretinal Space in RCS Rats
Invest. Ophthalmol. Vis. Sci., July 1, 2005; 46(7): 2552 - 2560.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
B.-L. L. Seagle, K. A. Rezai, Y. Kobori, E. M. Gasyna, K. A. Rezaei, and J. R. Norris Jr.
Melanin photoprotection in the human retinal pigment epithelium and its correlation with light-induced cell apoptosis
PNAS, June 21, 2005; 102(25): 8978 - 8983.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
K. Doi, J. Kong, J. Hargitai, S. P. Goff, and P. Gouras
Transient Immunosuppression Stops Rejection of Virus-Transduced Enhanced Green Fluorescent Protein in Rabbit Retina
J. Virol., October 15, 2004; 78(20): 11327 - 11333.
[Abstract] [Full Text] [PDF]


Home page
Br. J. Ophthalmol.Home page
F Willermain, L Caspers-Velu, B Nowak, P Stordeur, R Mosselmans, I Salmon, T Velu, and C Bruyns
Retinal pigment epithelial cells phagocytosis of T lymphocytes: possible implication in the immune privilege of the eye
Br. J. Ophthalmol., December 1, 2002; 86(12): 1417 - 1421.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
N. Kanuga, H. L. Winton, L. Beauchene, A. Koman, A. Zerbib, S. Halford, P.-O. Couraud, D. Keegan, P. Coffey, R. D. Lund, et al.
Characterization of Genetically Modified Human Retinal Pigment Epithelial Cells Developed for In Vitro and Transplantation Studies
Invest. Ophthalmol. Vis. Sci., February 1, 2002; 43(2): 546 - 555.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
H. Wenkel and J. W. Streilein
Evidence that Retinal Pigment Epithelium Functions as an Immune-Privileged Tissue
Invest. Ophthalmol. Vis. Sci., October 1, 2000; 41(11): 3467 - 3473.
[Abstract] [Full Text]


Home page
IOVSHome page
F. Willermain, L. Caspers–Velu, N. Baudson, C. Dubois, M. Hamdane, F. Willems, T. Velu, and C. Bruyns
Role and Expression of CD40 on Human Retinal Pigment Epithelial Cells
Invest. Ophthalmol. Vis. Sci., October 1, 2000; 41(11): 3485 - 3491.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1997 by the Association for Research in Vision and Ophthalmology